Assist. Prof. Dr. Jing-Da Qiao, Guangzhou Medical University, China

Jingda Qiao is a dedicated biomedical researcher with a multidisciplinary background in pharmaceutical engineering, neuroscience, and biomedical science. He holds a Bachelor’s degree in Pharmaceutical Engineering from Guangzhou University of Chinese Medicine, a Master’s degree in Neuroscience from Zhongshan School of Medicine at Sun Yat-sen University under the supervision of Prof. Huaiyu Gu, and a Ph.D. in Biomedical Science from The Chinese University of Hong Kong, mentored by Professors Wing-Ho Yung and Ya Ke. Jingda’s research focuses on the pathogenesis and treatment of neurodevelopmental disorders, combining genome-wide sequencing with transgenic animal models such as mice and Drosophila to investigate novel disease-related genes. He is also actively engaged in exploring the mechanisms of learning, memory, and neural plasticity using electrophysiology, live imaging, and behavioral analysis. His technical expertise spans electrophysiology, molecular biology, behavioral neuroscience, and analytical chemistry. Recognized for his academic excellence, Jingda has received prestigious honors including the Guangdong Overseas Postdoctoral Fellowship and selection as a Young Talent under Guangzhou’s Senior Ranking Personnel Program.

🏅 Summary of Suitability for Best Researcher Award

Dr. Jingda Qiao is a multidisciplinary biomedical scientist with strong academic foundations and hands-on expertise in neuroscience, biomedical science, and analytical chemistry. With advanced training across prestigious institutions in China and Hong Kong, his work bridges molecular, cellular, and behavioral neuroscience—making him a highly suitable candidate for the Best Researcher Award.

🎓 Education

🧪 Bachelor of Engineering
Major: Pharmaceutical Engineering
Institution: Guangzhou University of Chinese Medicine

🧠 Master of Science
Major: Neuroscience
Institution: Zhongshan School of Medicine, Sun Yat-sen University
Supervisor: Prof. Huaiyu Gu

🔬 Doctor of Philosophy (Ph.D.)
Major: Biomedical Science
Institution: The Chinese University of Hong Kong
Supervisors: Prof. Wing-Ho Yung and Prof. Ya Ke

🧪 Research Experience & Skills

🔋 Electrophysiology: Patch clamp (whole-cell), brain slice & in vivo LTP

🧬 Molecular Biology: PCR, Western blot, ELISA, flow cytometry, paraffin sectioning

🧠 Behavioral Studies: Rodent & Drosophila models for seizure, learning, memory

⚗️ Analytical Chemistry: GC-MS, HPLC, TOF-MS, UV-Vis, gel filtration, membrane separation

🔍 Microscopy: Laser scanning confocal & scanning electron microscopy

💡 Research Interests

🧠 Neurodevelopmental Disorders:

Gene identification via trio-based genome-wide sequencing
Use of transgenic mice and Drosophila to uncover disease mechanisms

🧠 Learning & Memory Mechanisms:

Applying electrophysiology, live imaging, and behavior analysis
Investigating synaptic plasticity and neural circuits involved in cognition

Publication Top Notes:

Investigation of epilepsy-related genes in a Drosophila model

<i>ZFHX3</i> variants cause childhood partial epilepsy and infantile spasms with favourable outcomes

Identification of novel pathogenic genes of childhood epileptic encephalopathies

Heterozygous Variants in KCNJ10 Cause Paroxysmal Kinesigenic Dyskinesia Via Haploinsufficiency

The Interaction ofUBR4, LRP1, andOPHN1in Refractory Epilepsy:DrosophilaModel to Investigate the Oligogenic Effect on Epilepsy

Iodine Acetonitrile as a Drinking Water Disinfectant Showed a Potential Toxic Effect on Organism

Dr. Gisella Campanelli | Cancer Therapeutics Awards | Best Researcher Award

Dr. Gisella Campanelli, Long Island University, United States

Gisella Campanelli holds a Ph.D. in Pharmaceutical Sciences with a specialization in molecular pharmacology and cancer biology from Long Island University, Brooklyn, NY. She is a Postdoctoral Research Fellow at Long Island University, where she investigates molecular mechanisms driving human prostate cancer and canine urothelial carcinoma, aiming to develop therapeutic strategies for treatment and prevention. With extensive experience in oncology research, she has worked on pharmacological target identification, in vivo cancer models, and experimental therapeutics. Previously, she was a Postdoctoral Associate at New York University, studying the role of neurons in the tumor microenvironment and oral cancer pain. Her background also includes a distinguished career as a hospital pharmacist in Australia, where she provided clinical services, managed pharmacy training programs, and served as an examiner for the Pharmacy Board of Australia. She has received numerous academic honors, including the Outstanding Ph.D. Student Award at Long Island University, and has contributed to peer-reviewed research through publications and journal reviews. Passionate about comparative pharmacology and oncology, she continues to advance research in both human and veterinary cancer therapeutics.

Professional Profile:

GOOGLE SCHOLAR

Summary of Dr. Gisella Campanelli

Dr. Gisella Campanelli is a highly accomplished researcher in pharmaceutical sciences, specializing in molecular pharmacology and cancer biology. She holds a Ph.D. in Pharmaceutical Sciences (Pharmacology) from Long Island University, with extensive experience investigating molecular drivers of human prostate cancer and canine urothelial carcinoma. Her research focuses on identifying pharmacological targets and developing therapeutic strategies for cancer treatment and prevention.

🎓 Education

Ph.D. in Pharmaceutical Sciences (Pharmacology) – Long Island University, Brooklyn, NY (2022)
Master of Science in Pharmacology and Toxicology – Long Island University, Brooklyn, NY (2017)
Master of Cultural Materials Conservation – University of Melbourne, Australia (2011)
Pharmacy Traineeship – Pharmacy Board of Australia & The Northern Hospital, Australia (1998)
Bachelor of Pharmacy – Victorian College of Pharmacy, Monash University, Australia (1997)

💼 Work Experience

Postdoctoral Research Fellow (Levenson Lab) – Long Island University, Brookville, NY (09/2023-Present)
🔬 Investigates molecular mechanisms driving human and canine prostate and urothelial carcinoma
🎯 Identifies pharmacological targets for cancer treatment and prevention
🧪 Studies the efficacy and safety of therapeutic agents for cancer management
Postdoctoral Associate (Ye Lab) – New York University, NY (04/2023-09/2023)
🧠 Researched the role of neurons in the tumor microenvironment
🔍 Investigated molecular mechanisms underlying oral cancer pain
Graduate Research Assistant (Vivarium) – Long Island University, Brooklyn, NY (06/2016-12/2022)
👩‍🏫 Trained and supervised student staff
📦 Managed orders for diets, bedding, and animal enrichment
🏥 Liaised with veterinarians and IACUC on animal welfare
Pharmacy Board Examiner – Pharmacy Board of Australia, Melbourne, Australia (10/2006-06/2012)
✍️ Composed examination questions for pharmacist registration
🏆 Examined pharmacy pre-registrants for licensure
Pharmacist – The Northern Hospital, Melbourne, Australia (11/1998-02/2011)
🏥 Provided clinical services to medical, surgical, and psychiatric inpatients
💊 Managed the clozapine program for psychiatric inpatients
🎓 Established and led a Board-recognized training program for pharmacy pre-registrants

🏆 Awards & Honors

Outstanding Ph.D. Student – Long Island University (2023) 🎖️
Best Poster – Long Island University Discovery Day (2022) 🏅
Best Poster – 10th Annual ACMAP Conference (2021) 🏆
Joan and Sam Williamson Pharmacy Graduate Fellowship – LIU Pharmacy (2020) 💰
Rho Chi Honor Society – LIU Pharmacy (2017) 🎓
Dame Joan Sutherland Grant – American Australian Association (2014) 🌏
Cultural Heritage Grant – Ian Potter Cultural Trust (2014) 🏛️
Dean’s Honor List – University of Melbourne (2011) 🏅
Graduate Intern Scholarship – University of Melbourne (2011) 🎓
Pharmacy Business Management Award – Australian Institute of Pharmacy Management (1997) 💼

Publication Top Notes:

MTA 1 drives malignant progression and bone metastasis in prostate cancer

CITED:30

Therapeutic potential of gnetin C in prostate cancer: A pre-clinical study

CITED:19

Dietary pterostilbene for MTA1-targeted interception in high-risk premalignant prostate cancer

CITED:12

Molecular Efficacy of Gnetin C as Dual‐Targeted Therapy for Castrate‐Resistant Prostate Cancer

CITED:07

Gnetin C intercepts MTA1-associated neoplastic progression in prostate cancer

CITED:07

Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Assist. Prof. Dr. Jing-Da Qiao | Medicine | Best Researcher Award

Assist. Prof. Dr. Jing-Da Qiao, Guangzhou Medical University, China

Professional Profile:

🏅 Summary of Suitability for Best Researcher Award